Wednesday, August 12, 2015

Antipsychotic Use Continues to Decrease Among Long-Stay Nursing Home Residents

AHCAPressOffice@ahca.org
The national prevalence of antipsychotic medication use in long-stay nursing home residents continues to decline, a report by the Centers for Medicare & Medicaid Services (CMS) shows. According to data compiled by the National Partnership to Improve Dementia Care in Nursing Homes – a public-private coalition under the direction of CMS – 18.7 percent of long-stay nursing home residents were receiving an antipsychotic medication in the first quarter of 2015 compared with 23.9 percent in the fourth quarter of 2011, representing a 21.7 percent decrease.

“This represents the progress we’ve made in bettering the lives of those we serve every day,” said Mark Parkinson, President and CEO of the American Health Care Association (AHCA). “Together with CMS and AHCA’s Quality Initiative, more than 35,000 nursing center residents living with dementia are no longer receiving antipsychotic medications. But we can’t stop there. We are working to safely reduce the use of the medication by a total of 30 percent over the next two years and are well on our way.” 

As of the first quarter of 2015, AHCA members have achieved a 23 percent decrease in the reduction of antipsychotic use.  Read the formal announcement on our website.



No comments:

Post a Comment